jump to the main content
jump to the bottom of the page

Contenido en español
Contingut en català
Current language Spanish

COLLABORATE El Meu Clínic

Contenido en español
Contingut en català
Current language Spanish

Noemí Reguart

Oncology Department Oncologist

Research group

Translational genomics and targeted therapies in solid tumours Accredited researcher (R3A)

nreguart@clinic.cat 0000-0001-8190-499X

Follow it on:

The Researchgate of Noemí . This link opens in a new tab.

Featured publications

Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer

Authors:
Wolf J; Seto T; Han JY; Reguart N; Garon EB;

(...)

Cui X; Giovannini M; Akimov M; Heist RS; GEOMETRY mono-1 Investigators.

Reference: New England Journal Of Medicine 2020.

Featured Projects

PEERs: A phase II trial of Lenvatinib, pembrolizumab and carboplatin-etoposide in extended-small cell lung cancer. Includes translational exploratory research to identify biomarkers in tissue samples.

Principal investigator: Noemi Reguart Aransay

Funder: MSD

Code: 2020-005230-15

Duration: 01/10/2020 - 01/10/2026
Validación de un Ensayo Multiplex Personalizado para la detección de Oncogenes y Firmas Inmunes en Cáncer de Pulmón (CP): Estudio Observacional, Prospectivo y Multicéntrico

Principal investigator: Noemi Reguart Aransay

Code: PI16/00890

Duration: 01/01/2017 - 01/01/2019